The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome

Background: Polycystic ovary syndrome (PCOS) is associated with an adverse cardiovascular risk profile including a prothrombotic state. Exenatide has been shown to be effective at improving insulin sensitivity and weight loss in PCOS; therefore this study was undertaken to assess its effects on weig...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawson, Alison J., Sathyapalan, Thozhukat, Vince, Rebecca, Coady, Anne-Marie, Ajjan, Ramzi A., Kilpatrick, Eric S., Atkin, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454834/
https://www.ncbi.nlm.nih.gov/pubmed/31001199
http://dx.doi.org/10.3389/fendo.2019.00189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454834/
https://www.ncbi.nlm.nih.gov/pubmed/31001199
http://dx.doi.org/10.3389/fendo.2019.00189

Ejemplares similares